Overview
Coronaviruses and immune response refers to the interaction between coronaviruses and the host immune system, encompassing how the body recognizes and defends against these RNA viruses and how viral infection in turn shapes immune activity. For SARS-CoV-2, the agent of COVID-19, the immune response is central to both protection and pathology, because excessive or dysregulated inflammation can contribute to severe disease. Innate and adaptive mechanisms are engaged, including interferon signaling, cytokine production, and antibody-mediated immunity. Research examines how the viral spike protein influences interferon induction and the balance of cytokine gene expression, illuminating how the virus modulates host defenses. Antibody-based strategies are also studied, including the use of neutralizing antibodies delivered through convalescent immune plasma to prevent or limit infection. Nutritional and immunomodulatory approaches feature as well, such as dietary mannose-binding lectins proposed to reduce infection risk and immune modulators intended to strengthen antiviral responses. Molecular characterization of SARS-CoV-2, including evolutionary analysis of spike sequences, links viral variation to immune recognition and the durability of protection. Understanding coronaviruses and immune response integrates virology and immunology to clarify how protective immunity develops, how immunopathology arises, and how vaccines, antibodies, and immunomodulators can be designed to favor effective defense while limiting harmful inflammation.
Research published in this journal
9 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Marginal SARS-CoV-2 Spike Protein Increases Interferon and Balances Cytokine Gene Expression
Reducing COVID-19 Risk through Dietary Supplementation of Plant Mannose Binding Lectins
Animals in the COVID-19 Era: Between Being a source, Victims, or Maybe our Hope to Overcome it!
SARS-CoV-2 affected cells Pathogeny and Therapy
Molecular Evolutionary Characteristics of the 2019 Novel Coronavirus (SARS-CoV-2) Contracted by Tunisian Citizens : Comparison and Relationship to Other Human and Animal Coronaviruses Based on Spike Glycoprotein-Coding Gene Sequences Analysis
Use of Immune Modulator Interferon-Gamma to Support Combating COVID-19 Pandemic
Presentation of Neutralizing Antibodies in Single- or Pooled-Convalescent Immune Plasma from Donors to Prevent the Current SARS-CoV-2 Pandemic
Features of the Emergence and Re-Emergence of Infectious Diseases, Geopolitics and Gain-of-Function Research
How this research is being cited
The 9 articles above have been cited 28 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2024 · German Journal of Pharmaceuticals and Biomaterials
-
2023 · Revista Brasileira de Farmacognosia
-
2023 · Revista Brasileira de Farmacognosia
-
Satadal Das et al. · 2023 · International Journal of Applied Biology
-
2023 · Frontiers in Medicine
-
2023 · Frontiers in Medicine
-
2022 · International Journal of Clinical Virology
-
2022 · International Journal of Clinical Virology
A sample of recent works citing this journal's research on Coronaviruses and Immune Response, linking to each citing work.